ABSTRACT The ability of Epstein-Barr virus (EBV) to establish latency allows it to evade the
immune system and to persist for the lifetime of its host; one distinguishing characteristic is …

Latent Epstein–Barr virus (EBV) infection and cellular hypermethylation are hallmarks of
undifferentiated nasopharyngeal carcinoma (NPC). However, EBV infection of normal oral …

Epstein Barr is the first-in-human oncogenic virus, closely related to numerous
lymphoproliferative and malignant diseases, including HL, BL, NPC, and GC. EBV …

Epstein–Barr virus (EBV) encodes multiple latency programs: a growth-transforming
program (type III) latency program and restricted-latency (types I and II) programs. During …

Epstein-Barr virus (EBV) establishes a life-long infection in humans, with distinct viral latency
programs predominating during acute and chronic phases of infection. Only a subset of the …

Epstein–Barr virus (EBV) is present in a state of latency in infected memory B-cells and EBV-
associated lymphoid and epithelial cancers. Cell stimulation or differentiation of infected B …

Abstract The Epstein–Barr virus (EBV) is a human gamma‐herpesvirus that is implicated in
various types of proliferative diseases. Upon infection, it predominantly establishes latency …

The Epstein–Barr virus (EBV) growth-transforms B-lymphocytes. The virus-encoded nuclear
antigen 2 (EBNA2) is essential for transformation and activates gene expression by …

The Epstein-Barr virus BZLF1 immediate-early gene encodes a transcriptional activator
protein, Zta, which acts as a key regulatory switch in the transition between the latent and …

Methylation-associated transcriptional repression is recognized in many settings and may
play a role in normal differentiation and in tumorigenesis. Both sequence-specific and …